Suppression of human lymphocyte DNA and protein synthesis in vitro by adenosine and eight modified adenine nucleosides in the presence or in the absence of adenosine deaminase inhibitors, 2'-deoxycoformycin (DCF) and erythro-9-(2-hydroxy-3-nonyl) adenine (EHNA).
D000225:Adenine / Q000031:analogs & derivatives / Q000494:pharmacology; D000241:Adenosine / Q000031:analogs & derivatives* / Q000494:pharmacology*; D058892:Adenosine Deaminase Inhibitors; D001798:Blood Proteins / Q000096:biosynthesis; D003070:Coformycin / Q000031:analogs & derivatives / Q000494:pharmacology; D004247:DNA / Q000096:biosynthesis; D006801:Humans; D066298:In Vitro Techniques; D008213:Lymphocyte Activation / Q000187:drug effects; D008214:Lymphocytes / Q000187:drug effects* / Q000378:metabolism; D015649:Pentostatin; D010835:Phytohemagglutinins / Q000494:pharmacology
D058892:Adenosine Deaminase Inhibitors; D001798:Blood Proteins; D010835:Phytohemagglutinins; D003070:Coformycin; D015649:Pentostatin; C010192:9-(2-hydroxy-3-nonyl)adenine; D004247:DNA; D000225:Adenine; D000241:Adenosine